Primary Hepatic Marginal zone Lymphoma: A rare coincidence
Primary hepatic lymphoma (PHL) is an extremely rare disease and is often misdiagnosed. The optimal therapy is still unclear and the outcomes are uncertain. Among PHLs, a primary hepatic low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is still rarer. The present study reports the case of an elderly female diagnosed with primary hepatic lymphoma (MALT lymphoma) and treated with single agent rituximab. After 18 months, she had a progressive disease and developed Waldenstorms Macroglobulinemia concomitantly.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Soumya Surath Panda, Manas Baisakh, Adyakinkar Panda, Hemlata Das Source Type: research
More News: Cancer | Cancer & Oncology | Lymphoma | Macroglobulinemia | Rare Diseases | Rituxan | Study | Waldenstrom's Macroglobulinemia